Showing 1 - 3 results of 3 for search 'Martin S Tallman', query time: 0.01s Refine Results
  1. 1
    Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year - the PROS

    Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year - the PROS by Martin S. Tallman

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction

    Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction by Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia

    The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia by John Barrett, Stephen J Forman, Jeffrey S Miller, Jill Brufsky, Jorge Cortes, Marcos de Lima, Michael M Boyiadzis, Ivan Aksentijevich, Daniel A Arber, Renier J Brentjens, Ephraim J Fuchs, Linda J Fukas, Steven D Gore, Mark R Litzow, John M Pagel, Martin S Tallman

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: